Feature Industry Review Pharmaceuticals

The Best Companies of the Pharmaceuticals Industry – August 2015

While ModernGraham supports the bottom-up approach to investing, many investors do utilize the top-down method, whereby an industry is selected before the company itself. With that in mind, this article will take a brief look at the best companies of the pharmaceuticals industry, selecting the most promising investment opportunities within the industry, and giving a broad look into the industry as a whole.

Read More
Feature Value Investing Weekly

27 Companies in the Spotlight This Week – 4/4/15

We evaluated 27 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. We also put each company through the ModernGraham valuation model based on Benjamin Graham’s value investing formulas in order to determine an intrinsic value for each. Here’s a summary of the ModernGraham Valuations.

Read More
Pharmaceuticals Stocks

Zoetis Inc. Quarterly Valuation – March 2015 $ZTS

Zoetis Inc. (ZTS) is suitable for the Enterprising Investor but not for the Defensive Investor. The Defensive Investor is concerned by the short operating history as a publicly traded company, along with the high PEmg and PB ratios. The Enterprising Investor is only initially concerned by the level of debt relative to the net current assets.

Read More
Feature Value Investing Weekly

14 Companies in the Spotlight This Week – 4/5/14

We looked at 14 different companies this week.  Here’s a summary of the ModernGraham Valuations.  For more detailed analysis, click on the name of the company.  To see screens of all of our valuations, be sure to get a copy of this month’s edition of ModernGraham Stocks and Screens! The Elite (Defensive or Enterprising and Undervalued) […]

Read More
Back To Top